New data from a Phase 1b clinical trial testing Fulcrum's pociredir for sickle cell disease are expected by the middle and ...

About Keros Therapeutics, Inc. Keros is a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that ...

For columnist Mary Shaniqua, one of the hardest aspects of sickle cell is its unpredictability, such as the sudden onset of a ...

This program comes after The Dallas Morning News and the San Antonio Express-News published a thorough investigation into preventable trauma deaths. The investigation showed that prehospital blood ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...

Study: Blood Transfusion Post-Heart Attack May Be Critical for Those with Anemia By Dennis Thompson HealthDay Reporter FRIDAY, Dec. 27, 2024 (HealthDay News) -- A blood transfusion following a ...

Unlike older Windows operating systems, Windows 10 has a lot of wonderful premium features. One of these is the well-designed icon for each of the system’s files. However, at some time, we all want to ...

Yes, it’s possible to experience iron deficiency, but not have iron deficiency anemia. “Iron deficiency anemia is just a later stage of iron deficiency,” says Dr. Casey O’Connell ...

FDA Accepted Agios’ Supplemental New Drug Application for PYRUKYND® (mitapivat) in Adult Patients with Non-Transfusion-Dependent and ...